Navigation Links
Investigational Genetic Test May Help Address Common Problems in Prostate Cancer Diagnosis
Date:4/29/2009

- Eight Studies Presented at Leading Urology Meeting Show that Simple Urine Test for PCA3 Gene May Improve Accuracy of Prostate Cancer Detection, Reduce Unnecessary Biopsies -

- Gen-Probe to Begin Pivotal Clinical Study in Effort to Gain U.S. Regulatory Approval -

SAN DIEGO, April 29 /PRNewswire-FirstCall/ -- Eight studies presented this week at the annual meeting of the American Urological Association (AUA) suggest that Gen-Probe's (Nasdaq: GPRO) investigational test for the highly specific prostate cancer gene PCA3 may help address some of the well-known challenges that urologists face when diagnosing prostate cancer, such as accurately identifying potentially aggressive cancers while minimizing "false positive" results that can lead to overtreatment.

In response to these studies and other promising data from approximately 17 peer-reviewed publications, Gen-Probe has decided to initiate a pivotal clinical study of its investigational PCA3 assay that could lead to regulatory approval by the U.S. Food and Drug Administration (FDA).

"Based on the results of our extensive clinical research studies and our European commercial experience, we believe that our PCA3 assay, when used in conjunction with other tests, can help predict the risk of a positive follow-up biopsy, thereby aiding in the diagnosis of prostate cancer," said Henry L. Nordhoff, Gen-Probe's chairman and chief executive officer. "We are pleased to be moving ahead with a U.S. clinical trial that could lead to improved patient care."

Gen-Probe's clinical study is expected to begin in the third quarter of 2009 and take about a year to complete. The Company anticipates it will involve more than 500 men, all of whom have had a negative prostate biopsy, at 10 or more clinical trial sites.

'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
2. A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol
3. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
4. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
5. Replidynes Investigational Antibacterial Agent REP3123 Prevents Sporulation in Clostridium difficile
6. Replidynes Investigational Antibacterial Agent REP3123 Prevents Toxin Production in Clostridium difficile
7. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
8. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
9. KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model
10. Lexicon Reports Initial Clinical Trial Results for LX1031, an Investigational New Drug for Irritable Bowel Syndrome
11. Roches Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... , May 1, 2015  Misonix, Inc. (NASDAQ: ... that designs, manufactures and markets innovative therapeutic ultrasonic ... debridement, cosmetic surgery, laparoscopic surgery and other surgical ... results for the third quarter fiscal year 2015 ... scheduled a conference call that same day, Thursday, ...
(Date:5/1/2015)... NEW YORK , May 1, 2015  Shares ... over 70% of their value yesterday following the results ... company,s glaucoma therapy, Rhopressa.  Despite the trial failing to ... indicates that positive results may come from future studies. ... a brief company overview, current pipeline, financial review, analyst ...
(Date:4/30/2015)... 2015 Omnicell, Inc. (NASDAQ: OMCL ), a ... healthcare systems, today announced results for its first quarter ... for the first quarter of 2015 was $116.2 million, ... of 2014, and down $5.3 million or 4.4% from ... 2015 net income as reported in accordance with U.S. ...
Breaking Medicine Technology:Misonix, Inc. To Report Third Quarter Fiscal Year 2015 Financial Results On Thursday, May 7, 2015 2All is Not Lost for Aerie Pharmaceuticals - VLM Research Issued by BrokerBank Securities, Inc. 2Omnicell Announces First Quarter 2015 Results 2Omnicell Announces First Quarter 2015 Results 3Omnicell Announces First Quarter 2015 Results 4Omnicell Announces First Quarter 2015 Results 5Omnicell Announces First Quarter 2015 Results 6Omnicell Announces First Quarter 2015 Results 7Omnicell Announces First Quarter 2015 Results 8Omnicell Announces First Quarter 2015 Results 9Omnicell Announces First Quarter 2015 Results 10Omnicell Announces First Quarter 2015 Results 11Omnicell Announces First Quarter 2015 Results 12Omnicell Announces First Quarter 2015 Results 13Omnicell Announces First Quarter 2015 Results 14Omnicell Announces First Quarter 2015 Results 15Omnicell Announces First Quarter 2015 Results 16Omnicell Announces First Quarter 2015 Results 17Omnicell Announces First Quarter 2015 Results 18Omnicell Announces First Quarter 2015 Results 19Omnicell Announces First Quarter 2015 Results 20Omnicell Announces First Quarter 2015 Results 21Omnicell Announces First Quarter 2015 Results 22Omnicell Announces First Quarter 2015 Results 23Omnicell Announces First Quarter 2015 Results 24Omnicell Announces First Quarter 2015 Results 25Omnicell Announces First Quarter 2015 Results 26Omnicell Announces First Quarter 2015 Results 27
... Mont., Feb. 1, 2012 Bacterin International Holdings ... leader in the development of revolutionary bone graft material ... Hayden IR , a 15-year-old, highly recognized, national investor ... relations program and raise its visibility and strengthen its ...
... 1, 2012  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ... Food and Drug Administration (FDA) has notified Arena that ... discuss the lorcaserin New Drug Application (NDA) resubmission will ... and details of the meeting will be published in ...
Cached Medicine Technology:Bacterin Retains Hayden IR to Develop Strategic Investor Relations Program 2Bacterin Retains Hayden IR to Develop Strategic Investor Relations Program 3Bacterin Retains Hayden IR to Develop Strategic Investor Relations Program 4Arena Pharmaceuticals Receives Notice from FDA of Advisory Committee Meeting for Lorcaserin 2Arena Pharmaceuticals Receives Notice from FDA of Advisory Committee Meeting for Lorcaserin 3Arena Pharmaceuticals Receives Notice from FDA of Advisory Committee Meeting for Lorcaserin 4
(Date:5/3/2015)... 2015 Indiana Fiber Network, LLC (IFN), ... Computer Services, Inc (BCS) has selected IFN as a ... “The technology, service, and working relationship with IFN has ... local feel you get with IFN. I like ... makes local decisions and operates as a local community ...
(Date:5/3/2015)... (PRWEB) May 03, 2015 SpineFrontier, a ... from the FDA to produce and market their new ... can be used in outpatient settings and is compatible ... alternate posterior approach has been extensively researched and refined ... approval to use this approach in conjunction with a ...
(Date:5/2/2015)... May 02, 2015 Ticket Down has secured ... for the long awaited event today, Saturday, May 2nd at ... boxing fans will be able to secure tickets for both ... fight that boxing fans have wanted for more than five ... Floyd “Money” Mayweather will step inside the ring to fight ...
(Date:5/2/2015)... New York, NY (PRWEB) May 02, 2015 ... – when a deadly natural disaster strikes anywhere on ... ways to leverage human sympathy and compassion for their ... US-CERT (United States Computer Emergency Readiness Team) issued ... warning users “of potential email scams citing the earthquake ...
(Date:5/2/2015)... 02, 2015 Kare Visits LLC. launched in ... busy caregivers. Kare Visits offers relief for caregivers by ... facilities. According to the Caregiver Action Network, eight ... of 20 hours a week caring for an elderly or ... to hire a nurse, a caregiver is now empowered to ...
Breaking Medicine News(10 mins):Health News:Bank Computer Services, Inc Selects Indiana Fiber Network, LLC as Fiber Transport Provider 2Health News:Bank Computer Services, Inc Selects Indiana Fiber Network, LLC as Fiber Transport Provider 3Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 2Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 4Health News:Chicagoan Seeks to Transform Industry by Launching an Innovative Elderly Care Solution 2
... 3 Health Care Service Corporation (HCSC),which operates the ... Oklahoma and Texas, today announced that its board of ... chief executive officer,effective Nov. 1, 2008., Hemingway Hall, ... since November 2007, will succeed Raymond F. McCaskey, who ...
... emergency physicians access to earn CME ... credit for watching online video procedures, NEW ... leading global provider of information resources for the,scientific and ... the largest membership organization for emergency,physicians, to launch Continuing ...
... Educational resources and special product offers available in store during ... American Diabetes Month ... retail pharmacy, is educating patients about managing and,preventing diabetes during ... during the month on products for patients,with diabetes., Nearly ...
... is available in German . , SARS, ... becoming increasingly frequent. And we still don,t have vaccines for ... classes of viral diseases is the zoonosis, which can be ... of these is caused by the West Nile virus (WNV), ...
... have found that reducing the levels of vascular endothelial growth ... new blood vessel growth, in adult mice causes the death ... that are essential to visual function. This finding, published in ... for the chronic use of promising new anti-VEGF drugs such ...
... Program; Inaugural Partner for ... Fund(R), LONDON, Nov. 3 Susan G. ... organization in the world, is teaming with,Samsung Electronics ... in Europe, in a collaboration unparalleled in the ...
Cached Medicine News:Health News:Hemingway Hall Named CEO of Health Care Service Corporation 2Health News:McGraw-Hill Professional and American College of Emergency Physicians Roll Out CME Functionality On AccessEmergency Medicine 2Health News:McGraw-Hill Professional and American College of Emergency Physicians Roll Out CME Functionality On AccessEmergency Medicine 3Health News:CVS/pharmacy Helps Patients Manage Diabetes Care 2Health News:Therapeutic vaccines 2Health News:Anti-VEGF drugs for retinal diseases could have serious side effects, scientists caution 2Health News:Anti-VEGF drugs for retinal diseases could have serious side effects, scientists caution 3Health News:Samsung and Susan G. Komen for the Cure(R) Launch Historic Breast Cancer Alliance 2Health News:Samsung and Susan G. Komen for the Cure(R) Launch Historic Breast Cancer Alliance 3
... instrument engineered to match the speed of ... system is based on heat transfer by ... tubes or thin walled micorcentrifuge tubes. Heating ... high velocity air results in nearly instantaneous ...
Contains: Card, cabling and instructions to remotely access a RoboCycler® instrument from a PC or Macintosh® computer...
... Biosystems has designed its 60-well, 0.5 mL ... PCR applications (both DNA and RNA). The ... Frame ensure oil-free operation in the 0.5 ... the 0.5 mL GeneAmp PCR System 9700 ...
... Mx3005P instrument and custom filter wheels ... filters. The standard filter set includes: ... ROX/Texas Red (585nm-610nm), Cy5 (635nm-665nm) and ... Mx3005P analysis software, Beacon Designer oligo ...
Medicine Products: